Aarti Drugs Limited has announced a significant leadership transition, with Shri Rashesh C. Gogri set to become Chairman in addition to his Managing Director role, and Shri Adhish P. Patil appointed as the new Managing Director. This change is effective from October 1, 2026, following the retirement of Shri Prakash M. Patil. The move aims to strengthen governance and ensure long-term strategic growth.
Aarti Drugs Announces Key Leadership Changes
Aarti Drugs Limited (ADL) has revealed a significant leadership transition aimed at enhancing governance and driving long-term strategic growth. The Board of Directors approved the elevation of Shri Rashesh C. Gogri to Chairman, a role he will hold concurrently with his position as Managing Director. Concurrently, Shri Adhish P. Patil has been appointed as the new Managing Director of the company. These changes are set to take effect from October 1, 2026.
Prakash M. Patil to Retire from Executive Roles
This transition marks the retirement of Shri Prakash M. Patil from his executive responsibilities as Chairman, Managing Director, and Chief Executive Officer. His stepping down from these active roles will be effective at the close of business hours on September 30, 2026. Shri Patil will continue to be associated with the company in an advisory capacity, providing guidance and strategic support to ensure a smooth transition.
Continuity and Future Growth
The company highlighted that these changes are a strategic step to strengthen ADL’s leadership bench and build upon its manufacturing scale, R&D capabilities, and customer relationships. Shri Gogri, who has been Managing Director since September 2014, brings extensive experience in the chemical and pharmaceutical industry. Shri Patil, the incoming Managing Director, has been the Chief Financial Officer since April 2014 and has been instrumental in the company’s financial and operational growth.
The leadership realignment is intended to foster a natural evolution of ADL’s governance framework, balancing continuity with renewal. By promoting leaders who have grown within the organization, the company aims to preserve institutional knowledge and technical expertise while positioning itself for faster and clearer execution across its various functions. This strategic succession planning ensures experienced leadership combined with fresh strategic thinking as Aarti Drugs continues to scale its operations.
Source: BSE
